| Financial Year |
March 31 2023 |
| Monetary Funds |
150,608,697.22 |
| Held-for-trading Financial Assets |
15,120,926.00 |
| Notes Receivable |
56,240.00 |
| Accounts Receivable |
1,100,139,580.23 |
| Advances to Suppliers |
226,977,786.75 |
| Other Receivables |
40,989,709.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
180,012,799.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,278,757.06 |
| Total Current Assets |
1,749,355,587.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
65,166,445.76 |
| Investment Properties |
3,851,387.65 |
| Fixed Assetes |
232,495,700.11 |
| Under-construction Projects |
2,761,063.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
48,499,732.93 |
| R&D expenses |
-- |
| Goodwill |
434,696,350.07 |
| Long-Term Deferred and Prepaid Expenses |
2,095,307.60 |
| Deferred Income Tax Assets |
72,661,808.82 |
| Other Non-Current Assets |
114,232,839.13 |
| Sub-Total of Non-Current Assets |
1,318,368,773.27 |
| Total Assets |
3,067,724,361.21 |
| Short-Term Loans |
422,546,598.41 |
| Trading Financial liabilities |
-- |
| Notes Payable |
78,432,212.00 |
| Accounts Payable |
288,700,177.26 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,141,734.20 |
| Taxes Payable |
4,275,469.33 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
691,442,021.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
149,064,389.45 |
| Other Current Liabilities |
26,554,343.41 |
| Sub-Total of Current Liabilities |
1,827,115,872.36 |
| Long-term Loans |
310,750,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
29,400,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
5,604,702.50 |
| Deferred Income Tax Liabilities |
26,920,210.91 |
| Other Non-Current Liabilities |
13,644,238.14 |
| Sub-Total of Non-Current Liabilities |
564,690,433.03 |
| Total Liabilities |
2,391,806,305.39 |
| Paid-In Capital(Or Share Stock) |
531,943,475.00 |
| Capital Surplus |
121,579,220.59 |
| Surplus Reserve |
37,166,316.30 |
| LESS:Treasury Stock |
37,336,824.09 |
| Undistributed Profits |
-47,033,472.59 |
| Minority Stockholder's Interest |
70,939,487.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
604,978,568.67 |
| Owner's Equity（Stockholder's Equity） |
675,918,055.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,067,724,361.21 |
